Israeli Medical Aesthetics Firm InMode Set for $1.1B Acquisition Deal
InMode, the Israeli medical aesthetics technology company, is in advanced talks for a $1.1 billion acquisition by a foreign investment fund, representing a 25% premium.
NOTRELOAD AI
Sarepta's Elevidys Gene Therapy Shows Lasting Benefits Three Years After Treatment for Duchenne Muscular Dystrophy
Sarepta Therapeutics reports positive three-year results for Elevidys gene therapy in Duchenne patients, showing 70% slowing of disease progression and sustained motor function improvements, boosting investor confidence.
Enphase Energy Cuts 160 Jobs as Solar Tax Credit Expires
Enphase Energy announces 6% workforce reduction and restructuring plan following expiration of federal solar tax credit. Stock drops 3.7% premarket.
Nvidia Invests $2B in CoreWeave to Build Massive AI Data Centers by 2030
Nvidia purchases $2 billion CoreWeave stake at $87.20/share to build 5 gigawatts of AI factories by 2030, nearly doubling investment in AI infrastructure partner.
JPMorgan Raises Apple Price Target to $315 Ahead of Earnings
JPMorgan lifts Apple price target to $315, citing strong iPhone 17 demand despite higher memory costs, and maintains an Overweight rating.
Needham Turns Bullish on AppLovin with $700 Price Target
Needham upgrades AppLovin to Buy, raising its price target to $700 and boosting 2026 e-commerce revenue forecasts due to stronger advertiser growth.